Antibe Therapeutics to Present at 2021 Bloom Burton & Co. Healthcare Investor Conference
Wednesday, April 14th 2021 at 11:00am UTC TORONTO–(BUSINESS WIRE)– Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company…
Wednesday, April 14th 2021 at 11:00am UTC TORONTO–(BUSINESS WIRE)– Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company…
Wednesday, January 27th 2021 at 10:00am UTC Demonstrates its Commitment to Environmental Leadership Focus on Energy Conservation, Renewable Energy and…
Wednesday, May 19th 2021 at 8:00am UTC Synthace Hires Guy Levy-Yurista as Chief Executive Officer LONDON–(BUSINESS WIRE)– Synthace Ltd, the…
Monday, May 17th 2021 at 12:00pm UTC Phase 1 healthy volunteer study demonstrates that oral administration of IMB-101 is well…
Thursday, May 20th 2021 at 12:11pm UTC DUBLIN–(BUSINESS WIRE)– The « Biosensors Market Size, Share & Trends Analysis Report by Application…
Wednesday, May 19th 2021 at 10:27pm UTC New data analyses from the Phase 3 ARIEL3 and ARIEL4 trials further characterize…
Friday, May 21st 2021 at 5:24pm UTC RBX2660 pivotal Phase 3 trial successfully met the primary endpoint; data presented today…
Tuesday, May 18th 2021 at 3:15pm UTC DUBLIN–(BUSINESS WIRE)– The « Global Robotic Surgery System Market 2021-2025 » report has been added…
Monday, May 17th 2021 at 10:00am UTC Accelerating Discovery by Providing High Throughput Spatial Analysis of any RNA Target in…
Thursday, May 20th 2021 at 1:04pm UTC Mailia and Silvina each have decades of biopharma experience with a deep understanding…